Muse Cell Clinic Checklist: 7 Research-Backed Questions to Ask Before Booking
Medically reviewed by Dr. Charles Pereyra, MD — Medical Director, Springs Rejuvenation. Last reviewed October 7, 2026.
Written by the Springs Rejuvenation regenerative medicine team from direct clinical experience administering stem cell and exosome protocols at our Aventura, Miami center.
Interest in Muse cell therapy has grown quickly in the United States, and with it, the number of clinics using the term. Because this field is investigational, the burden is on patients to vet providers carefully. The following checklist is grounded in how Muse cells are actually studied in the peer-reviewed literature.
The 7 Questions
1. Where do your cells come from, and are they SSEA-3-selected? Muse cells are defined in research by SSEA-3 selection. A clinic should document provenance.
2. Which physician evaluates my candidacy? Published trials enrolled patients under physician-led protocols with inclusion and exclusion criteria. At Springs Rejuvenation, every candidate is evaluated by a physician-led team under Dr. Charles Pereyra before any therapy discussion.
3. Can you cite the research behind your protocol? Credible programs reference studies such as Noda 2020 (first-in-human CL2020 Muse-based product in heart attack patients) and Niizuma 2023 (a randomized stroke trial). If a clinic cannot name its evidence, that is a signal.
4. What outcomes does the evidence actually support? The honest framing is that early trials are encouraging but limited in size, and Muse cell therapy is not FDA approved. Beware of guarantees.
5. What safety monitoring do you perform? Research protocols include screening labs and structured follow-up. A clinic should describe its own monitoring plan.
6. Who should NOT receive this therapy? A quality clinic screens people out. If everyone qualifies, no one is being evaluated.
7. Will you coordinate with my existing physicians? Regenerative care works best inside, not outside, your broader medical picture.
Why This Standard Matters
Dr. Pereyra's position at Springs Rejuvenation is that a muse cell clinic should hold itself to the standards of the research it cites — documented cell quality, physician oversight, honest expectations, and structured follow-up. That approach lets patients explore an emerging field without abandoning medical rigor, and without traveling overseas to less regulated environments.
How do I know if a muse cell clinic is legitimate?
Look for physician-led evaluation, documented cell provenance, citations to peer-reviewed research, and plain acknowledgment that the therapy is investigational.
Should I travel abroad for muse cell therapy?
US-based care under physician oversight allows screening, monitoring, and follow-up that are hard to replicate across borders. Characterized Muse cell programs now exist domestically, including at Springs Rejuvenation.
What research should a muse cell clinic know?
At minimum: Dezawa's foundational characterization work, Yamada 2018 on the S1P-S1PR2 homing mechanism, Noda 2020's first-in-human safety data, and the Niizuma 2023 randomized stroke trial.
What should a clinic tell me about results?
That individual responses vary, early trial data are encouraging but preliminary, and no outcome can be promised.
Medical Disclaimer: Stem cell and exosome therapy is not an FDA approved therapy and is considered to be in the experimental stages. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Springs Rejuvenation processes exosomes in an FDA approved lab. Individual results may vary. This content is reviewed for medical accuracy by Dr. Charles Pereyra, MD, Medical Director of Springs Rejuvenation, and is provided for educational purposes only. Always consult a qualified physician.